News

On Take Your Dog to Work Day, HABRI and Dechra Partner to Strengthen the Human-Animal Bond

The Human Animal Bond Research Institute (HABRI) and Dechra, a global animal health company focused on veterinary specialty care, marked “Take Your Dog to Work Day” by announcing a new partnership to advance their shared mission of supporting the human-animal bond through research, education and advocacy.

Dechra Launches Catney® One: A New Tool for Feline Kidney Health

Catney One® provides veterinarians another option to combat phosphate absorption, a key challenge in maintaining feline kidney health

Dechra Announces FDA Approval of Otiserene® (marbofloxacin, terbinafine, and dexamethasone otic suspension) the latest treatment for canine otitis externa

First single-dose, long-acting otitis externa product leveraging marbofloxacin

One More Step for Not One More Vet

This World Vet Day (April 26, 2025), Dechra – a leading global animal health company, launched its ‘One More Step for Not One More Vet’ campaign in its continued support of a veterinary mental health charity.

Dechra Launches DuOtic®: The First Antibiotic-Free Otitis Externa Treatment for Dogs

A first-to-market, antibiotic-free approach to treating canine ear infections with long-lasting relief and increased antimicrobial stewardship

Dechra Expands Commitment to Veterinary Profession with New American Veterinary Medical Foundation Scholarships

Nearly $50,000 in scholarships continues a decade-long effort of supporting veterinary students and now expands to veterinary technicians

Dechra Pharmaceuticals Limited (Dechra) today announces the appointment of a new North American President

Laura Olsen will join Dechra as the new President of North America, effective September 9, bringing a wealth of experience in animal and human health, having previously worked at Zoetis, Pfizer, and Novartis.

Dechra Pharmaceuticals Limited (Dechra) announces the upcoming acquisition of Invetx

In line with its long-term strategy to be an innovation leader in health, Invetx specializes in developing protein-based therapeutics for companion animals' chronic conditions, focusing on monoclonal antibodies (mAbs).

Dechra Pharmaceuticals Limited today announces the appointment of Jesper Nordengaard as its CEO and retirement of Ian Page effective June 10, 2024

Jesper Nordengaard will join Dechra from Colgate-Palmolive where he is currently President, North America. Jesper previously was President and CEO of Hill’s Pet Nutrition, an iconic global pet food brand anchored in science and recommendation.

Dechra teams up with Fear Free to elevate veterinary care for pets

Dechra, a global leader in animal health, is excited to announce its strategic alliance with Fear Free®, an organization committed to reducing fear, anxiety, and stress in pets during veterinary visits. Through this collaboration, Dechra reinforces its commitment to seeing things from the veterinary perspective by supporting the Fear Free mission.